Workshop: Going Public After the JOBS Act

  • Changes to Sarbanes-Oxley, changes to Regulation A, and the IPO on-ramp

    Tuesday, January 8th: 9:45AM – 10:45AM

    The Jumpstart Our Business Startups (JOBS) Act includes a number of important changes for companies considering going public. The so-called “IPO on-ramp” providing scaled disclosure obligations and Sarbanes-Oxley relief for companies under $1 billion in revenues who are doing IPOs is a very important development. In addition, there are new rules providing greater access to investors for analysts, and more opportunities to publish research around the IPO. The law also includes major changes to Regulation A, which permits a simplified IPO with an SEC-approved offering circular. These changes are hoped to attract more companies to use Regulation A as an easier way to get public. The JOBS Act even makes many reverse mergers with shell companies more attractive as well.

    Topics covered will include: How does the new IPO on-ramp actually work? What are its benefits? Are there any downsides to taking advantage of the on-ramp? What additional research can now be published around an IPO? How can analysts have more time with investors under the bill? What are the Regulation A changes and when will they be effective? What will be the advantages and disadvantages of a Regulation A IPO? Does the JOBS Act have any benefits for companies that went public before the law? How are reverse mergers more attractive after the JOBS Act?

    Faculty:

    David N. Feldman is a Partner of Richardson & Patel in its New York City office. His practice focuses on corporate and securities matters and general representation of public and private companies, investment banks, private equity firms and high net worth individuals. He also actively advises on mergers and acquisitions and private equity, debt, venture capital and other financings.

    David is considered one of the country’s leading experts on alternatives to traditional initial public offerings, including reverse mergers, in which a private company becomes publicly traded through a merger with a publicly held “shell” company. His book on the subject, Reverse Mergers and Other Alternatives to a Traditional IPO, Second Edition was originally published in 2006, has been translated into Chinese and the second edition was released in December 2009. In 2011, TheStreet.com labeled the book the “seminal text” on reverse mergers. David’s blog, www.reversemergerblog.com, is visited by thousands of professionals each month.

     

    Nimish P. Patel, JD/MBA/CPA is a co-founder and managing partner at Richardson & Patel, LLP. Mr. Patel’s primary focus is corporate and securities laws and is well versed in drafting complex business transactional documents. Mr. Patel’s experience includes mergers and acquisitions for private and public companies, angel and venture capital financing, IPOs, Secondary Offerings, PIPEs, and other financing and corporate restructurings. Mr. Patel currently advises several publicly traded companies on corporate governance and assists company management with their Form 10K, 10Q, 8K, Proxies and other regulatory filing requirements with the Securities and Exchange Commission and the National Exchanges.

    Mr. Patel has an extensive accounting and finance background to complement his legal education and experience. Prior to joining his law firm, Mr. Patel worked as a senior auditor for the auditing firm of Deloitte & Touche LLP, where he had the opportunity to work on several initial public offerings and large and complex corporate reorganizations for both private and public companies.
     

  • Conference Info:

     

    Date: June 26-27, 2013
    Location: The Metropolitan Club, New York City


    Audience: Institutional investors, high net worth individual investors, family offices, business development executives throughout the US and Europe building and financing high growth medical technology, health care and life science companies.

    View the Schedule!

    View the Agenda!